CAS: 269726-79-6; (R)-3-Amino-4-(2-Cyanophenyl)Butanoic Acid Hydrochloride

该化合物是一个有机化合物,其特点是氨基酸结构,包括氨基氨基酸组和一个碳本酸组,该化合物具有氰化苯基酸组,表明一个苯基环中存在一个半氰酸组(EuroCN),该组有助于其化学反应和在各个领域,包括制药和生物化学领域的潜在应用.氨基配置表明,氨基酸组位于 ----相对于碳,影响其立体化学和生物活动.该化合物可能具有氨基酸的典型特性,例如水中的溶性以及参与浸泡物联结形成的能力.其独特结构允许与生物系统进行潜在互动,使其对医药化学和药物设计感兴趣.与许多氨基酸一样,它也可以在代谢途径中发挥作用,或者作为更复杂的分子的建筑块.

结构式图片

MSDS等安全信息

    合成工艺路线路线简述

      海关参考信息

      专利信息


      专利号:US-2022243244-A1
      优先权日:2019-10-10
      标 题 :Compositions and methods for in vivo synthesis of unnatural polypeptides
      发明人:ROMESBERG FLOYD E; FISCHER EMIL C; HASHIMOTO KOJI; FELDMAN AARON W; DIEN VIVIAN T; ZHANG YORKE
      权利人:SCRIPPS RESEARCH INST
      摘要:Disclosed herein are compositions, methods, and kits for a cell incorporating unnatural amino acids into an unnatural polypeptide. Also disclosed herein are compositions, methods, and kits for increasing activity and yield of the unnatural polypeptide synthesized by the cell.

      专利号:US-2023037284-A9
      优先权日:2018-11-30
      标题:Combination therapy of peptidomimetic macrocycles
      发明人:GUERLAVAIS VINCENT; ANNIS DAVID ALLEN
      权利人:AILERON THERAPEUTICS INC
      摘要:The present disclosure describes the synthesis of peptidomimetic macrocycles and methods of using peptidomimetic macrocycles to treat a condition. The present disclosure also describes methods of using peptidomimetic macrocycles in combination with at least one additional pharmaceutically-active agent for the treatment of a condition, for example, cancer.

      专利号:US-2025084410-A1
      优先权日:2015-01-12
      标 题:Incorporation of unnatural nucleotides and methods thereof
      发明人:PTACIN JEROD; MALYSHEV DENIS A; CAFFARO CAROLINA E
      权利人:SYNTHORX INC
      摘要:Disclosed herein are methods, compositions and kits for the synthesis of proteins which comprises unnatural amino acids that utilize a mutant tRNA.

      专利号:US-2018371021-A1
      优先权日:2017-05-11
      标 题 :Peptidomimetic macrocycles and uses thereof
      发明人:AIVADO MANUEL; GUERLAVAIS VINCENT; OLSON KAREN
      权利人:AILERON THERAPEUTICS INC
      摘要:The present disclosure describes the synthesis of peptidomimetic macrocycles and methods of using peptidomimetic macrocycles to treat a condition. The present disclosure also describes methods of using peptidomimetic macrocycles in combination with at least one additional pharmaceutically-active agent for the treatment of a condition, for example, cancer.

      专利号:WO-2021072167-A1
      优先权日:2019-10-10
      标 题:Compositions and methods for in vivo synthesis of unnatural polypeptides

      专利号:US-11091522-B2
      优先权日:2018-07-23
      标题 :Peptidomimetic macrocycles and uses thereof
      发明人:AIVADO MANUEL; GUERLAVAIS VINCENT; OLSON KAREN; ANNIS DAVID ALLEN
      权利人:AILERON THERAPEUTICS INC
      摘要:The present disclosure describes the synthesis of peptidomimetic macrocycles and methods of using peptidomimetic macrocycles to treat a condition. The present disclosure also describes methods of using peptidomimetic macrocycles in combination with at least one additional pharmaceutically-active agent for the treatment of a condition, for example, cancer.
      上海恒创生物科技有限公司
      ⚠️ 未注册 · 未认证企业
      ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
      数据来源于公开网络搜索,平台未作核实,请自行辨别。
      🏢敬请 企业认领
      🏬开设公司展台
      📢获取免费会员权益
      🎖️点亮专属注册企业标签
      📇展现公司完整信息 样本查看立即注册认领 →
      网址: http://www.hcbiotech.com.cn
      电话: 021-20227858👤
      📞上海恒创生物科技有限公司 ⚠️参考联系方式

      销售电话:021-20227858
      邮箱:sale@hcbiotech.com.cn
      🆔 联系时候可告知是从"百琢研"平台获取的信息.
      ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

      ⚠️ 未注册 · 未认证企业
      注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
      第 1 / 1 页
      现货

      供应商参考报价(招募中)

      品牌试剂参考报价(招募中)

      📌 第三方产品分析报告

      ✅ COA系统入驻 | 共享模式
      📝 需求与反馈
      尽可能描述清楚需求与问题信息
      ×

      通知